Blindness News and Research

RSS

Researchers take key step toward developing a gene therapy for Usher syndrome type 1F

Usher Syndrome type 1F is a rare but severe genetic disease that causes deafness, lack of balance, and progressive blindness.

26 Apr 2023

Clinical trial may set a new 'gold standard' for the treatment of childhood craniopharyngioma

St. Jude Children's Research Hospital is reporting phase 2 clinical trial results treating the brain tumor craniopharyngioma with proton therapy.

19 Apr 2023

University Hospital Bonn coordinates eWHORM project to combat worm infections in sub-Saharan Africa

African and European partners join forces to enable the World Health Organisation's (WHO) "Road Map for Neglected Tropical Diseases" (NTDs) and reduce the burden of disease associated with worm infections.

11 Apr 2023

Study explores the association between gut microbiome dysbiosis and uveitis

Researchers provide an overview of existing research on the correlation between uveitis and gut dysbiosis.

7 Apr 2023

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless sex, according to findings published today in the New England Journal of Medicine.

6 Apr 2023

Membrane attack complex could be a potential therapeutic target to slow or prevent AMD

A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD), a common cause of vision loss in older adults.

3 Apr 2023

FDA-approved drug keeps light-sensitive photoreceptors alive in lab models of LCA 10

A National Institutes of Health team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 (LCA 10), an inherited retinal ciliopathy disease that often results in severe visual impairment or blindness in early childhood.

29 Mar 2023

Dormant cone photoreceptors in the degenerating retina may retain visual function, research suggests

New UCLA research in mice suggests that "dormant" cone photoreceptors in the degenerating retina are not dormant at all, but continue to function, producing responses to light and driving retinal activity for vision.

27 Mar 2023

Blind people superior at sensing their heartbeats than sighted individuals

Blind people are better at sensing their own heartbeats than sighted, shows a study by researchers at Karolinska Institutet in Sweden and Jagiellonian University in Poland.

24 Mar 2023

California picks generic drug company Civica to produce low-cost insulin

Gov. Gavin Newsom on Saturday announced the selection of Utah-based generic drug manufacturer Civica to produce low-cost insulin for California, an unprecedented move that makes good on his promise to put state government in direct competition with the brand-name drug companies that dominate the market.

19 Mar 2023

CRISPR-based genome editing restores the vision of mice with retinitis pigmentosa

Researchers in China have successfully restored the vision of mice with retinitis pigmentosa, one of the major causes of blindness in humans.

17 Mar 2023

Injectable peptide used for type 2 diabetes shows potential for treating 'blinding' IIH headaches

Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension could be treated with an injectable peptide used for type 2 diabetes, a new trial has found.

13 Mar 2023

Newly identified therapeutic target could lead to more effective treatment of glaucoma

Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma.

10 Mar 2023

The role of caffeine in preventing diabetic retinopathy

Moderate and high caffeine intake offered protection against the development of diabetic retinopathy.

5 Mar 2023

Face blindness may be more common than currently believed

Face blindness, a mystifying condition that can trick us into believing we recognize people we've never met or make us fail to recognize those we have, has been previously estimated to affect between 2 and 2.5 percent of people in the world.

27 Feb 2023

Research identifies potential treatment target for infantile spasms syndrome

New research from Tufts University School of Medicine and the Graduate School of Biomedical Sciences suggests that the timing of the death of certain inhibitory neurons in the brain shortly after birth may be at least partly to blame for infantile spasms syndrome (ISS), a rare but devastating form of epilepsy that develops most frequently between four and eight months of age but can emerge within weeks of birth until ages 4 or 5.

21 Feb 2023

Blindness News and Research

Researchers take key step toward developing a gene therapy for Usher syndrome type 1F

Clinical trial may set a new 'gold standard' for the treatment of childhood craniopharyngioma

University Hospital Bonn coordinates eWHORM project to combat worm infections in sub-Saharan Africa

Study explores the association between gut microbiome dysbiosis and uveitis

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

Membrane attack complex could be a potential therapeutic target to slow or prevent AMD

FDA-approved drug keeps light-sensitive photoreceptors alive in lab models of LCA 10

Dormant cone photoreceptors in the degenerating retina may retain visual function, research suggests

Blind people superior at sensing their heartbeats than sighted individuals

California picks generic drug company Civica to produce low-cost insulin

CRISPR-based genome editing restores the vision of mice with retinitis pigmentosa

Injectable peptide used for type 2 diabetes shows potential for treating 'blinding' IIH headaches

Newly identified therapeutic target could lead to more effective treatment of glaucoma

The role of caffeine in preventing diabetic retinopathy

Face blindness may be more common than currently believed

Research identifies potential treatment target for infantile spasms syndrome

Two new zebrafish models for studying the most common cause of Leigh syndrome developed

Study provides a rare view of real-world use of off-label drugs prescribed for Type 1 diabetes

Researchers aim to better understand how myopia management strategies affect children

Intracranial pressure plays a key role in normal-tension glaucoma

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News